Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5220872
Max Phase: Preclinical
Molecular Formula: C24H26Cl2FN3O
Molecular Weight: 462.40
Associated Items:
ID: ALA5220872
Max Phase: Preclinical
Molecular Formula: C24H26Cl2FN3O
Molecular Weight: 462.40
Associated Items:
Canonical SMILES: O=C(c1ccc(Cl)c(Cl)c1)N1CCC(CNCCCc2c[nH]c3ccc(F)cc23)CC1
Standard InChI: InChI=1S/C24H26Cl2FN3O/c25-21-5-3-17(12-22(21)26)24(31)30-10-7-16(8-11-30)14-28-9-1-2-18-15-29-23-6-4-19(27)13-20(18)23/h3-6,12-13,15-16,28-29H,1-2,7-11,14H2
Standard InChI Key: XZVXVADHNMPBHV-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 462.40 | Molecular Weight (Monoisotopic): 461.1437 | AlogP: 5.69 | #Rotatable Bonds: 7 |
Polar Surface Area: 48.13 | Molecular Species: BASE | HBA: 2 | HBD: 2 |
#RO5 Violations: 1 | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: 10.31 | CX LogP: 5.28 | CX LogD: 2.54 |
Aromatic Rings: 3 | Heavy Atoms: 31 | QED Weighted: 0.44 | Np Likeness Score: -1.32 |
1. Yuan RX, Jiang KY, Wu JW, Zhang ZX, Li MS, Li JQ, Ni F.. (2022) Synthesis and antidepressant activity of novel 1-(1-benzoylpiperidin-4-yl) methanamine derivatives selectively targeting SSRI/5-HT1A., 76 [PMID:36202190] [10.1016/j.bmcl.2022.129006] |
Source(1):